Skip to content
Tuesday, June 23, 2026
  • Home
  • About Us
  • Contact Us
  • Our Team
  • Privacy Policy
  • Term Of Services
Funds Pulse
  • Mutual Fund
  • Index Funds
  • Personal Finance
  • Insurance
  • Other Funds

Our Team

Mateo Edwards
Author
Email
Zoey Ortiz
Editor
Email
Charles Kim
Author
Email
Kennedy Ruiz
Editor
Email
Jameson Sanders
Author
Email

Recent Posts

  • ACTIVIST SHAREHOLDER FILES SCHEDULE 13D IN EQUUS TOTAL RETURN, INC.
  • CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World’s First Bispecific Antibody for Passive Immunization Against Rabies
  • The Pool Factory Strengthens Its Position as a Leading U.S. Provider of Above Ground Pools and Outdoor Living Products
  • Sui News: Cumberland, Fluid, and SwissBorg Join Institutional Coalition on Hashi Ahead of July Global Testnet
  • X-tosis Receives Grant from The Michael J. Fox Foundation to Advance Novel Parkinson’s Disease Therapy

Categories

  • Mutual Fund
  • Index Funds
  • Personal Finance
  • Insurance
  • Other Funds
Vehement Finance News Network

ACTIVIST SHAREHOLDER FILES SCHEDULE 13D IN EQUUS TOTAL RETURN, INC.

By fundspulse_acousc June 23, 2026
Vehement Finance News Network

CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World’s First Bispecific Antibody for Passive Immunization Against Rabies

By fundspulse_acousc June 23, 2026
Vehement Finance News Network

The Pool Factory Strengthens Its Position as a Leading U.S. Provider of Above Ground Pools and Outdoor Living Products

By fundspulse_acousc June 23, 2026
Vehement Finance News Network

Sui News: Cumberland, Fluid, and SwissBorg Join Institutional Coalition on Hashi Ahead of July Global Testnet

By fundspulse_acousc June 23, 2026

About Us

Funds Pulse is financial information source. We provide investment advice, analysis and information through our website.

Caregories

  • Index Funds
  • Insurance
  • Mutual Fund
  • Other Funds
  • Personal Finance
  • Vehement Finance News Network

Latest Post

  • ACTIVIST SHAREHOLDER FILES SCHEDULE 13D IN EQUUS TOTAL RETURN, INC.
  • CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World’s First Bispecific Antibody for Passive Immunization Against Rabies
  • The Pool Factory Strengthens Its Position as a Leading U.S. Provider of Above Ground Pools and Outdoor Living Products
  • Sui News: Cumberland, Fluid, and SwissBorg Join Institutional Coalition on Hashi Ahead of July Global Testnet
  • X-tosis Receives Grant from The Michael J. Fox Foundation to Advance Novel Parkinson’s Disease Therapy
Theme of Rigorous Themes